Pharmaceutical Development Technician – Chemical Process Development

Bristol-Myers Squibb
0 reviews

Posted on: 12 Feb 2021

New Brunswick, NJ

Apply on Company site Save this job

Job Description

At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.

This position will perform in process analysis for the IPC kilo-lab that provides support for the synthesis/manufacturing of the API used toxicology, clinical and drug product development.

The Pharmaceutical Development Technician (PDT) - Process Analytical Sciences performs tests and assays for in-process samples utilizing a variety of test equipment including High Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), spectrophotometers, Karl Fischer apparatus, among others. Laboratory responsibilities include the preparation and proper labeling of standards, samples, reagents, glassware storage and cleaning, and general laboratory housekeeping. The PDT maintains laboratory documentation and equipment under strict compliance with GLP & GMP standards as well as federal, state and local regulations. The PDT also assists in the development and validation of analytical methods under the direct supervision of a scientist or laboratory supervisor.

Some projects require working in potent compound/containment areas using established procedures.

Position Requirements:

A minimum of an Associates Degree in the life sciences (Chemistry, Biology, etc.) or 5 years related work experience in bulk fine chemicals, bulk API or petrochemical analysis in a manufacturing or R&D environment is required. Must be proficient in the use and operation of all related laboratory, analytical, and computer equipment. Must perform tasks with high degree of accuracy and attention to detail. Must be a team player who can work in a collaborative environment. Must be able to work rotating shifts and/or extended work hours as requested

Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.

Bristol-Myers Squibb

New York, New York

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers drugs in oncology, immunoscience, cardiovascular, and fibrotic diseases. The company’s products include Opdivo, a biological product for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia, a biological product for adult patients with moderately to severely active RA and prostate-specific antigen, as well as reducing signs and symptoms in certain pediatric patients with moderately to severely active polyarticular juvenile idiopathic arthritis.

It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; and Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B. In addition, the company offers Reyataz, a protease inhibitor for the treatment of human immunodeficiency virus (HIV) and Evotaz; Sustiva franchise, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV; and Daklinza NS5A replication complex inhibitor, Sunvepra NS3 protease inhibitor, and Beclabuvir NS5B inhibitor. It sells products to wholesalers, retail pharmacies, hospitals, government entities, and medical profession. It has collaboration agreements with Nektar Therapeutics; Janssen Pharmaceuticals, Inc.; Biocartis Group NV.; and FameWave Ltd.

The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.